DELEAGE JEAN 4
4 · IDM PHARMA, INC. · Filed Aug 18, 2005
Insider Transaction Report
Form 4
IDM PHARMA, INC.IDMI
DELEAGE JEAN
Director
Transactions
- Award
Non-Qualified Stock Option
2005-08-16+2,857→ 2,857 totalExercise: $6.99From: 2005-09-16Exp: 2015-08-15→ Common Stock (2,857 underlying) - PurchaseSwap
Common Stock
2005-08-16+236,380→ 236,380 total(indirect: See footnotes.) - PurchaseSwap
Common Stock
2005-08-16+134,995→ 134,995 total(indirect: See footnotes.) - PurchaseSwap
Common Stock
2005-08-16+8,909→ 8,909 total(indirect: See footnotes.)
Footnotes (9)
- [F1]The shares of common stock were acquired in an exchange of shares of IDM S.A. for the shares of IDM Pharma, Inc. At the time of the exchange, each share of IDM S.A. was exchanged for 3.771865 shares of IDM Pharma, Inc. common stock, and adjusted for a 1 for 7 reverse stock split of the common stock of IDM Pharma, Inc.
- [F2]The shares are beneficially owned by Alta BioPharma Partners, L.P.
- [F3]N/A
- [F4]Alta Partners ("AP") provides investment advisory services to venture capital funds including Alta BioPharma Partners, L.P. ("ABP"), IDM Chase Partners (Alta Bio), LLC ("Chase") and Alta Embarcadero BioPharma Partners, LLC ("AEBP"). The respective general partner, managing directors, managing member and members of ABP, Chase and AEBP exercise sole voting and investment power with respect to the shares owned by such funds. Certain principals of AP are managing directors of Alta BioPharma Management, LLC (which is the general partner of ABP), members of AEBP and members of Alta/Chase BioPharma Management, LLC (which is the managing member of Chase). As managing directors and members of such entitites, they may be deemed to share voting and investment powers for the shares held by the funds. The principals of AP disclaim beneficial ownership of all such shares held by the foregoing funds except to the extent of their proportionate pecuniary interests therein.
- [F5]Upon the effective date of the share exchange and related transactions, Jean Deleage became a director of IDM Pharma, Inc. Dr. Deleage is a managing director of Alta BioPharma Management, LLC (which is the general partner of Alta BioPharma Partners L.P.("ABP")), a member of Alta Embarcadero BioPharma Partners LLC ("AEBP")and a managing director of Alta/Chase BioPharma Management LLC (Chase) (which is the managing member of IDM Chase Partners (Alta Bio), LLC). As a managing director and member of such entities, he may be deemed to share voting and investment powers over the shares held by such funds. As a principal of Alta Partners, he disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of his proportionate pecuniary interests therein.
- [F6]The shares are beneficially owned by IDM Chase Partners (Alta Bio), LLC.
- [F7]The shares are beneficially owned by Alta Embarcadero BioPharma Partners, LLC.
- [F8]Grant to reporting person of a non-qualified stock option to purchase shares of the common stock of IDM Pharma, Inc. pursuant to the terms of the Company's 2000 Stock Plan.
- [F9]The option vests in forty-eight (48) equal installments over four four years from 08/16/2005, the date of appointment to the Board of Directors. The first installment vests and is exercisable on 09/16/2005, and the option will be fully vested on 08/16/2009.